The Jerusalem PostLod mayor ‘seething’ after Jewish-Arab clashes, right-wing activist summoned for questioningInquirerIlocos Sur town sets P180 minimum farmgate price for live hogsPunchDon’t politicise sports, Presidency tells Obi over Flamingos greetingDaily MaverickRENEWABLES CRISIS : Pele’s governance test: Why a private boardroom matters to SA’s energy transitionZDF heuteEntdecken Sie das ZDF-NachrichtenstudioSRF NewsSchauspieler und Comedian – Über zehn Jahre Haft für Russell BrandIl Fatto QuotidianoLe renne che nuotano per la migrazione invernale: le incredibili immagini che arrivano dalla Norvegia – VIDEOCollider‘The Acolyte’ Director’s New Thriller Officially Scores ‘The Wheel of Time’ StarScreen RantPlayStation Officially Announces All-New ConsoleDigital Spy"What is going on?": Former Strictly star Oti Mabuse hits out at the judges' scoringCBS NewsHow to qualify for credit card debt forgiveness in 2027ABC NewsRussell Brand sentenced to 10 years 6 months in prison for rape, sexual assault
KioskNews
The Daily Newsstand · Free, Always
Monday, November 9, 2026
Language
Seeking Alpha·United States·

Whitehawk Therapeutics GAAP EPS of -$0.23 misses by $0.01

Translate

Gaurav Batavia

  • Whitehawk Therapeutics press release (WHWK): Q3 GAAP EPS of -$0.23 misses by $0.01.
  • Cash, cash equivalents and short-term investments as of September 30, 2026, were $169.7 million as compared to $145.7 million as of December 31, 2025. Cash is anticipated to fund operations into 2H 2028 based on current plans.

Recommended For You

Create Your Free Account to Keep Reading

Get the confidence to navigate an uncertain market with free breaking news and stock alerts.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.